SCHEMBL6364996

SCHEMBL6364996

C=CCn1c(C=CC=O)cc2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
PARP1 P09874 1/20 0.38
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP2C9 P11712 1/20 0.36
PTK2B Q14289 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RAB9A P51151 2/20 0.35
MAPT P10636 2/20 0.35
HRH1 P35367 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364991 1.00 LMNA (0.40) LMNAKDM4EALDH1A1HPGDPARP1
SCHEMBL14387230 0.84 LMNA (0.41) LMNAKDM4EALDH1A1HPGDPARP1
SCHEMBL6370665 0.79 PARP1 (0.38) LMNAKDM4EALDH1A1HPGDPARP1
SCHEMBL6370673 0.79 PARP1 (0.38) LMNAKDM4EALDH1A1HPGDPARP1
SCHEMBL6368595 0.79 KDM4E (0.39) LMNAKDM4EALDH1A1HPGDCYP1A2
SCHEMBL6369104 0.75 MAPK1 (0.45) LMNAKDM4EALDH1A1HPGDPOLB
SCHEMBL18912080 0.75 ALDH1A1 (0.39) LMNAKDM4EALDH1A1HPGDPARP1
SCHEMBL6364102 0.74 LMNA (0.45) LMNAKDM4EALDH1A1SMN1; SMN2RAB9A
SCHEMBL6364105 0.74 LMNA (0.45) LMNAKDM4EALDH1A1SMN1; SMN2RAB9A
SCHEMBL21803732 0.73 GRIN2D (0.47) LMNAKDM4EALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070591-A1 Indole derivative KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-03-31 US disclosed
EP-1464645-A1 INDOLE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070591-A1 Indole derivative TPH1, IDO1, RBX1 LMNA 4014/4885KDM4E 1406/4885ALDH1A1 1318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.